Danaher Corporation vs Lithium Americas Corp — how do they compare? Danaher Corporation trades at $218.41 (market cap $152.87B), while Lithium Americas Corp trades at $2.4 (market cap $850.38M). The key difference: Danaher Corporation is far larger — about 179.8× Lithium Americas Corp's market cap, and Danaher Corporation pays a 0.74% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Lithium Americas Corp for 27 Days on average.
| DHR | LAC | |
|---|---|---|
Market Cap | $152.87B | $850.38M |
Volume | 5,228,698 | 8,804,637 |
Sector | Health | Basic Materials |
52-Week High | $242.05 | $10.05 |
52-Week Low | $161.91 | $2.36 |
Typical Hold Time | 69 Days | 27 Days |
Enterprise Value | $175.08B | $1.19B |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Lithium Americas (LAC) trades at $2.41, down 5.12% in the last session, reflecting ongoing market pressure despite recent earnings beats. The company shows negative profitability metrics with a -9.56% ROE and -$122.09M net income for 2025, though it maintains strong financing activity with $1.14B in cash flow from financing. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators suggest potential oversold conditions. Recent news highlights construction progress at Thacker Pass as a key development catalyst.
The investment outlook remains speculative with significant execution risk at Thacker Pass offset by analyst optimism (46.67% buy rating) and a $4.00 consensus price target representing 66% upside. Key risks include lithium price volatility, project execution challenges, and sustained negative cash flow from operations. The stock's current valuation at 0.6x book value may attract value investors betting on successful project commercialization.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →